THIS SITE IS INTENDED FOR U.S. AUDIENCES ONLY.

Celgene

HEALTHCARE PROFESSIONAL RESOURCES

  • Metastatic Breast Cancer

    The ABRAXANE Journey: A History of Looking Ahead

    Learn about the role ABRAXANE plays in treatment of MBC, NSCLC, and MPAC through the stories of patients, caregivers, advocacy groups and the principal investigators of the ABRAXANE pivotal trials.

    ABRAXANE Reconstitution Video

    This video will guide you through the appropriate process of reconstituting ABRAXANE.

    ABRAXANE Full Prescribing Information

    Download the Prescribing Information for ABRAXANE.

    ABRAXANE is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.

    CLOSE THE TAB
  • Advanced Non–Small
    Cell Lung Cancer

    Reel Responses, Reel Stories

    Watch trusted oncologists share insights on the treatment landscape for advanced NSCLC, and the role chemotherapy plays today.
    See more in the series

    Advanced Squamous NSCLC and the Assessment of Tumor Response Video

    Explore the characteristics of advanced squamous NSCLC and its clinical manifestations.

    The ABRAXANE Journey: A History of Looking Ahead

    Learn about the role ABRAXANE plays in treatment of MBC, NSCLC, and MPAC through the stories of patients, caregivers, advocacy groups and the principal investigators of the ABRAXANE pivotal trials.

    ABRAXANE Reconstitution Video

    This video will guide you through the appropriate process of reconstituting ABRAXANE.

    Understanding Squamous NSCLC Through Virtual Reality

    A novel, 360-degree virtual reality experience that transports you inside the lung to understand the characteristics of advanced squamous NSCLC and its clinical manifestations from a new perspective. Set up a presentation in your office today.

    ABRAXANE Full Prescribing Information

    Download the Prescribing Information for ABRAXANE.

    ABRAXANE is indicated for the first-line treatment of locally advanced or metastatic non–small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy.

    CLOSE THE TAB
  • Metastatic
    Pancreatic Cancer

    Reel Responses, Reel Stories

    Watch trusted oncologists from across the country share their feelings of hope surrounding the ability to create a treatment plan for their MPAC patients.
    See more in the series

    The ABRAXANE Journey: A History of Looking Ahead

    Learn about the role ABRAXANE plays in treatment of MBC, NSCLC, and MPAC through the stories of patients, caregivers, advocacy groups and the principal investigators of the ABRAXANE pivotal trials.

    MPACT Study Videos

    Dr. George Kim reviews the MPACT study–the largest multinational Phase III study in metastatic pancreatic cancer (MPAC) using ABRAXANE + gemcitabine in the first-line setting.

    MPACT Study Design
    Dr. Kim presents the study design and results in the MPACT study.

    MPACT Efficacy
    Dr. Kim presents the efficacy results for ABRAXANE in the MPACT study (including OS, ORR, and PFS).

    MPACT Safety
    Dr. Kim presents the safety results for ABRAXANE in the MPACT study.

    MPACT Dosing
    Dr. Kim presents dosing and schedule recommendations for ABRAXANE in the MPACT study.

    ABRAXANE Reconstitution Video

    This video will guide you through the appropriate process of reconstituting ABRAXANE.

    NEJM Clinical Reprint

    Results from the Phase III Study: ABRAXANE plus gemcitabine for MPAC.

    MPAC Dosing Card

    Dosing Instructions for ABRAXANE MPAC indication including starting dose/schedule and dose modifications for certain treatment-related adverse reactions.

    MPAC NCCN Flashcard

    Learn about ABRAXANE + gemcitabine’s NCCN Category 1 recommendation in metastatic pancreatic cancer patients with good performance status (ECOG 0-1) and as a reasonable option for patients with KPS 70.

    ABRAXANE Full Prescribing Information

    Download the Prescribing Information for ABRAXANE.

    ABRAXANE is indicated for the first-line treatment of patients with metastatic adenocarcinoma of the pancreas, in combination with gemcitabine.

    NEJM Clinical Reprint

    Results from the Phase III Study: ABRAXANE plus gemcitabine for MPAC.

    MPAC Dosing Card

    Dosing Instructions for ABRAXANE MPAC indication including starting dose/schedule and dose modifications for certain treatment-related adverse reactions.

    MPAC NCCN Flashcard

    Learn about ABRAXANE + gemcitabine’s NCCN Category 1 recommendation in metastatic pancreatic cancer patients with good performance status (ECOG 0-1) and as a reasonable option for patients with KPS 70.

    ABRAXANE Full Prescribing Information

    Download the Prescribing Information for ABRAXANE.

    ABRAXANE is indicated for the first-line treatment of patients with metastatic adenocarcinoma of the pancreas, in combination with gemcitabine.

    CLOSE THE TAB
  • Metastatic Breast Cancer

    The ABRAXANE Journey: A History of Looking Ahead

    Learn about the role ABRAXANE plays in treatment of MBC, NSCLC, and MPAC through the stories of patients, caregivers, advocacy groups and the principal investigators of the ABRAXANE pivotal trials.

    ABRAXANE Reconstitution Video

    This video will guide you through the appropriate process of reconstituting ABRAXANE.

    ABRAXANE Full Prescribing Information

    Download the Prescribing Information for ABRAXANE.

    ABRAXANE is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.

    CLOSE THE TAB
  • Advanced Non–Small Cell Lung Cancer

    Reel Responses, Reel Stories

    Watch trusted oncologists share insights on the treatment landscape for advanced NSCLC, and the role chemotherapy plays today.
    See more in the series

    Advanced Squamous NSCLC and the Assessment of Tumor Response Video

    Explore the characteristics of advanced squamous NSCLC and its clinical manifestations.

    The ABRAXANE Journey: A History of Looking Ahead

    Learn about the role ABRAXANE plays in treatment of MBC, NSCLC, and MPAC through the stories of patients, caregivers, advocacy groups and the principal investigators of the ABRAXANE pivotal trials.

    ABRAXANE Reconstitution Video

    This video will guide you through the appropriate process of reconstituting ABRAXANE.

    Understanding Squamous NSCLC Through Virtual Reality

    A novel, 360-degree virtual reality experience that transports you inside the lung to understand the characteristics of advanced squamous NSCLC and its clinical manifestations from a new perspective. Set up a presentation in your office today.

    ABRAXANE Full Prescribing Information

    Download the Prescribing Information for ABRAXANE.

    ABRAXANE is indicated for the first-line treatment of locally advanced or metastatic non–small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy.

    CLOSE THE TAB
  • Metastatic Pancreatic Cancer

    Reel Responses, Reel Stories

    Watch trusted oncologists from across the country share their feelings of hope surrounding the ability to create a treatment plan for their MPAC patients.
    See more in the series

    The ABRAXANE Journey: A History of Looking Ahead

    Learn about the role ABRAXANE plays in treatment of MBC, NSCLC, and MPAC through the stories of patients, caregivers, advocacy groups and the principal investigators of the ABRAXANE pivotal trials.

    MPACT Study Videos

    Dr. George Kim reviews the MPACT study–the largest multinational Phase III study in metastatic pancreatic cancer (MPAC) using ABRAXANE + gemcitabine in the first-line setting.

    MPACT Study Design
    Dr. Kim presents the study design and results in the MPACT study.

    MPACT Efficacy
    Dr. Kim presents the efficacy results for ABRAXANE in the MPACT study (including OS, ORR, and PFS).

    MPACT Safety
    Dr. Kim presents the safety results for ABRAXANE in the MPACT study.

    MPACT Dosing
    Dr. Kim presents dosing and schedule recommendations for ABRAXANE in the MPACT study.

    ABRAXANE Reconstitution Video

    This video will guide you through the appropriate process of reconstituting ABRAXANE.

    NEJM Clinical Reprint

    Results from the Phase III Study: ABRAXANE plus gemcitabine for MPAC.

    MPAC Dosing Card

    Dosing Instructions for ABRAXANE MPAC indication including starting dose/schedule and dose modifications for certain treatment-related adverse reactions.

    MPAC NCCN Flashcard

    Learn about ABRAXANE + gemcitabine’s NCCN Category 1 recommendation in metastatic pancreatic cancer patients with good performance status (ECOG 0-1) and as a reasonable option for patients with KPS 70.

    ABRAXANE Full Prescribing Information

    Download the Prescribing Information for ABRAXANE.

    ABRAXANE is indicated for the first-line treatment of patients with metastatic adenocarcinoma of the pancreas, in combination with gemcitabine.

    NEJM Clinical Reprint

    Results from the Phase III Study: ABRAXANE plus gemcitabine for MPAC.

    MPAC Dosing Card

    Dosing Instructions for ABRAXANE MPAC indication including starting dose/schedule and dose modifications for certain treatment-related adverse reactions.

    MPAC NCCN Flashcard

    Learn about ABRAXANE + gemcitabine’s NCCN Category 1 recommendation in metastatic pancreatic cancer patients with good performance status (ECOG 0-1) and as a reasonable option for patients with KPS 70.

    ABRAXANE Full Prescribing Information

    Download the Prescribing Information for ABRAXANE.

    ABRAXANE is indicated for the first-line treatment of patients with metastatic adenocarcinoma of the pancreas, in combination with gemcitabine.

    CLOSE THE TAB

RESOURCES FOR YOUR PATIENTS

  • Metastatic
    Breast Cancer
    Metastatic Breast Cancer
    MBC Ambassador Stories

    One of the most valuable sources of support are other people who are facing the challenge of metastatic breast cancer (MBC). At Celgene, we call them ambassadors.

    They are patients, caregivers, and dedicated professionals who choose to share their stories and experiences with others.

    These videos are resources for your patients. The videos are available on the patient website, and patients should be directed to the patient site to view them.

    Patients & Caregivers

    Sarah and Sheila's Story

    Sarah shares her personal story of being diagnosed with and living with MBC, being a mother of small children and treatment with ABRAXANE. Sarah’s mother Sheila also shares what it's like to be a mother of someone living with MBC and how she supports her daughter while dealing with the disease. You will also hear from Tammy English, a registered oncology nurse, who will discuss MBC and ABRAXANE as a possible treatment option.

    Della and Kathy's Story

    Della and her sister Kathy share Della's story of being diagnosed and living with MBC. They also talk about the challenges overcoming financial hurdles, treatment with ABRAXANE, and how Kathy supported her. You will also hear from Tammy English, a registered oncology nurse, who will discuss MBC and ABRAXANE as a possible treatment option.

    Carol and Gene's Story

    Carol and her husband/caregiver Gene, talk about the value of family, their story of living with MBC, and treatment with ABRAXANE. Gene provides perspective as a caregiver on how difficult it can be to deal with a loved one being diagnosed, and helpful ways to support them through this trying time.

    Social Workers

    Seeking Balance: Full Video

    Sage Bolte, a licensed clinical social worker discusses working towards emotional balance, the importance of communication and additional resources to assist you after being diagnosed with and while living with metastatic breast cancer.

    Seeking Balance: Working Towards Emotional Balance

    Guilt is such a hard feeling for us to carry; it is so critical that you remind yourself if guilt comes up that you did not ask for this diagnosis, you did not ask for the cancer… sharing with your friends and family what you’re feeling, that your feeling guilty about the changes it’s creating in your family and having a conversation about that can be really helpful.”
    — Sage Bolte, PhD, LCSW, OSW-C

    Seeking Balance: Tips for Communicating

    They won’t know what they don’t know so if you’re concerned, if you’re worried, if you have a discomfort or pain, if you feel anxious, make sure to tell your healthcare team."
    — Sage Bolte, PhD, LCSW, OSW-C

    Resources to Assist

    We have the tendency to want to be super moms or super workers or super wives or super colleagues or super patients. And sometimes, we need to just accept our limits that we can’t necessarily run the marathon we used to. But we can walk to the mailbox today, and that today is an accomplishment."
    — Sage Bolte, PhD, LCSW, OSW-C

    Patient Brochures

    Preparing for My Treatment

    Show your patients items they may want to have on hand before their treatment begins. The list also includes arrangements they might want to make ahead of time so they get the support they may need during treatment with ABRAXANE.

    Doctor Visit Discussion Guide

    Helps your patients talk about treatment with ABRAXANE before treatment begins.

    Questions for My Healthcare Team

    Lists frequently asked questions about ABRAXANE and provides space for your patients to write down questions.

    Treatment Diary

    Helps your patients stay organized by keeping track of appointments and any symptoms they may experience so that they become more aware of how treatment with ABRAXANE may affect them.

    ABRAXANE is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.

    CLOSE THE TAB
  • Advanced Non–Small
    Cell Lung Cancer
    Advanced Non–Small Cell Lung Cancer
    Patient Brochures

    Preparing for My Treatment

    Show your patients items they may want to have on hand before their treatment begins. The list also includes arrangements they might want to make ahead of time so they get the support they may need during treatment with ABRAXANE.

    Doctor Visit Discussion Guide

    Helps your patients talk about treatment with ABRAXANE before treatment begins.

    Questions for My Healthcare Team

    Lists frequently asked questions about ABRAXANE and provides space for your patients to write down questions.

    Treatment Diary

    Helps your patients stay organized by keeping track of appointments and any symptoms they may experience so that they become more aware of how treatment with ABRAXANE may affect them.

    ABRAXANE is indicated for the first-line treatment of locally advanced or metastatic non–small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy.

    Treatment Diary

    Helps your patients stay organized by keeping track of appointments and any symptoms they may experience so that they become more aware of how treatment with ABRAXANE may affect them.

    ABRAXANE is indicated for the first-line treatment of locally advanced or metastatic non–small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy.

    CLOSE THE TAB
  • Metastatic
    Pancreatic Cancer
    Metastatic Pancreatic Cancer
    Patient Brochures

    Preparing for My Treatment

    Show your patients items they may want to have on hand before their treatment begins. The list also includes arrangements they might want to make ahead of time so they get the support they may need during treatment with ABRAXANE.

    Doctor Visit Discussion Guide

    Helps your patients talk about treatment with ABRAXANE before treatment begins.

    Questions for My Healthcare Team

    Lists frequently asked questions about ABRAXANE and provides space for your patients to write down questions.

    Treatment Diary

    Helps your patients stay organized by keeping track of appointments and any symptoms they may experience so that they become more aware of how treatment with ABRAXANE may affect them.

    Treatment Diary

    Helps your patients stay organized by keeping track of appointments and any symptoms they may experience so that they become more aware of how treatment with ABRAXANE may affect them.

    ABRAXANE is indicated for the first-line treatment of patients with metastatic adenocarcinoma of the pancreas, in combination with gemcitabine.

    CLOSE THE TAB

REEL RESPONSES, REEL STORIES

Reel Responses, Reel Stories Logo

Reel Responses, Reel Stories is a video series that explores the many dimensions of treating patients with metastatic pancreatic cancer and non–small cell lung cancer. Leading experts in the field share their triumphs and tribulations, first-hand insights on the treatment landscape, stories about caring for patients with difficult-to-treat cancers, and the role of ABRAXANE for appropriate patients. Watch the videos below, as we examine the emotional aspects of being an oncologist for both metastatic pancreatic cancer and advanced non–small cell lung cancer.

Reel Responses, Reel Stories is a video series that explores the many dimensions of treating patients with metastatic pancreatic cancer and non–small cell lung cancer. Leading experts in the field share their triumphs and tribulations, first-hand insights on the treatment landscape, stories about caring for patients with difficult-to-treat cancers, and the role of ABRAXANE for appropriate patients. Watch the videos below, as we examine the emotional aspects of being an oncologist for both metastatic pancreatic cancer and advanced non–small cell lung cancer.

Reel Responses, Reel Stories:
Advanced Non–Small Cell Lung Cancer

Watch trusted oncologists share insights on the treatment landscape for advanced NSCLC, and the role chemotherapy plays today.

Reel Responses, Reel Stories:
Metastatic Pancreatic Cancer

Watch trusted oncologists from across the country share their feelings of hope surrounding the ability to create a treatment plan for their MPAC patients.

SIGN UP FOR ADDITIONAL INFORMATION

There were errors with your submission. Please review the red fields below and try submitting again.

REQUEST AN OFFICE VISIT

There were errors with your submission. Please review the red fields below and try submitting again.

Please select one or more options below: